The (CGG)n repeat element within the 5′ untranslated region of the FMR1 message provides both positive and negative cis effects on in vivo translation of a downstream reporter

Human Molecular Genetics

Volumn 12, Issue 23, 2003, Pages 3067-3074

  Chen, Li Sheng ^a   Tassone, Flora ^a   Sahota, Parminder ^a   Hagerman, Paul J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; FRAGILE X MENTAL RETARDATION PROTEIN; LUCIFERASE; MESSENGER RNA;

5' UNTRANSLATED REGION; ALLELE; ARTICLE; CONTROLLED STUDY; DOWNSTREAM PROCESSING; FRAGILE X SYNDROME; GENE CONSTRUCT; GENE EXPRESSION; GENE MUTATION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKOCYTE; MENTAL DEFICIENCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROCESSING; REPORTER GENE; TRINUCLEOTIDE REPEAT;

5' UNTRANSLATED REGIONS; CELL LINE; FRAGILE X MENTAL RETARDATION PROTEIN; GENES, REPORTER; HUMANS; LUCIFERASES; NERVE TISSUE PROTEINS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; RNA-BINDING PROTEINS; TRANSCRIPTION, GENETIC; TRINUCLEOTIDE REPEAT EXPANSION;

CUCUMBER MOSAIC VIRUS;

EID: 0344668735     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg331     Document Type: Article

References (44)

1. Verkerk, A.J., Pieretti, M., Sutcliffe, J.S., Fu, Y.H., Kuhl, D.P., Pizzuti, A., Reiner, O., Richards, S., Victoria, M.F., Zhang, F.P. et al. (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 65, 905-914.
2. Bardoni, B. and Mandel, J.L. (2002) Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes. Curr. Opin. Genet. Dev., 12, 284-293.
3. Dorn, M.B., Mazzocco, M.M. and Hagerman, R.J. (1994) Behavioral and psychiatric disorders in adult male carriers of fragile X. J. Am. Acad. Child Adolesc. Psychiat., 33, 256-264.
4. Riddle, J.E., Cheema, A., Sobesky, W.E., Gardner, S.C., Taylor, A.K., Pennington, B.F. and Hagerman, R.J. (1998) Phenotypic involvement in females with the FMR1 gene mutation. Am. J. Ment. Retard., 102, 590-601.
5. Hagerman, R.J. and Hagerman, P.J. (2002) The fragile X premutation: into the phenotypic fold. Curr. Opin. Genet. Dev., 12, 278-283.
6. Allingham-Hawkins, D.J., Babul-Hirji, R., Chitayat, D., Holden, J.J., Yang, K.T., Lee, C., Hudson, R., Gorwill, H., Nolin, S.L., Glicksman, A. et al. (1999) Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study-preliminary data. Am. J. Med. Genet., 83, 322-325.
7. Schwartz, C.E., Dean, J., Howard-Peebles, P.N., Bugge, M., Mikkelsen, M., Tommerup, N., Hull, C., Hagerman, R., Holden, J.J. and Stevenson, R.E. (1994) Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am. J. Med. Genet., 51, 400-402.
8. Hagerman, R.J., Leehey, M., Heinrichs, W, Tassone, E, Wilson, R., Hills, J., Grigsby, J., Gage, B. and Hagerman, P.J. (2001) Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology, 57, 127-130.
9. Brunberg, J.A., Jacquemont, S., Hagerman, R.J., Berry-Kravis, E.M., Grigsby, J., Leehey, M.A., Tassone, F., Brown, W.T., Greco, C.M. and Hagerman, P.J. (2002) Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. AJNR Am. J. Neuroradiol., 23, 1757-1766.
10. Greco, C.M., Hagerman, R.J., Tassone, E, Chudley, A.E., Del Bigio, M.R., Jacquemont, S., Leehey, M. and Hagerman, P.J. (2002) Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain, 125, 1760-1771.
11. Jacquemont, S., Hagerman, R.J., Leehey, M., Grigsby, J., Zhang, L., Brunberg, J.A., Greco, C., Des Portes, V, Jardini, T., Levine, R. et al. (2003) Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am. J. Hum. Genet., 72, 869-878.
12. Berry-Kravis, E., Lewin, E, Wuu, J., Leehey, M., Hagerman, R., Hagerman, P. and Goetz, C.G. (2003) Tremor and ataxia in fragile X premutation carriers: blinded videotape study. Ann. Neurol., 53, 616-623.
13. Tassone, E, Hagerman, R.J., Taylor, A.K., Gane, L.W., Godfrey, T.E. and Hagerman, P.J. (2000) Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in fragile X syndrome. Am. J. Hum. Genet., 66, 6-15.
14. Kenneson, A., Zhang, F., Hagedorn, C.H. and Warren, S.T. (2001) Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum. Mol. Genet., 10, 1449-1454.
15. Primerano, B., Tassone, F, Hagerman, R.J., Hagerman, P., Amaldi, F. and Bagni, C. (2002) Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. RNA, 8, 1482-1488.
16. Napierala, D. and Slomski, R. (1998) [Regulation of human DMD gene expression. An example of multiple utilization of genetic information]. Postepy Biochem., 44, 48-55.
17. Chiang, P.W., Carpenter, L.E. and Hagerman, P.J. (2001) The 5′-untranslated. region of the FMR1 message facilitates translation by internal ribosome entry. J. Biol. Chem., 276, 37916-37921.
18. Shimizu, M., Gellibolian, R., Oostra, B.A. and Wells, R.D. (1996) Cloning, characterization and properties of plasmids containing CGG triplet repeats from the FMR-1 gene. J. Mol. Biol., 258, 614-626.
19. Hirst, M.C. and White, P.J. (1998) Cloned human FMR1 trinucleotide repeats exhibit a length- and orientation-dependent instability suggestive of in vivo lagging strand secondary structure. Nucl. Acids Res., 26, 2353-2358.
20. Trinh, T.Q. and Sinden, R.R. (1991) Preferential DNA secondary structure mutagenesis in the lagging strand of replication in E. coli. Nature, 352, 544-547.
21. Kang, S., Ohshima, K., Shimizu, M., Amirhaeri, S. and Wells, R.D. (1995) Pausing of DNA synthesis in vitro at specific loci in CTG and CGG triplet repeats from human hereditary disease genes. J. Biol. Chem., 270, 27014-27021.
22. Tassone, F., Hagerman, R.J., Loesch, D.Z., Lachiewicz, A., Taylor, A.K. and Hagerman, P.J. (2000) Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am. J. Med. Genet., 94, 232-236.
23. Muller-Hartmann, H., Deissler, H., Naumann, F., Schmitz, B., Schroer, J. and Doerfler, W. (2000) The human 20-kDa. 5′-(CGG)(n)-3′-binding protein is targeted to the nucleus and affects the activity of the FMR1 promoter. J. Biol. Chem., 275, 6447-6452.
24. Kozak, M. (1986) Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc. Natl Acad. Sci. USA, 83, 2850-2854.
25. Kozak, M. (1989) Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs. Mol. Cell. Biol., 9, 5134-5142.
26. Bouvet, P., Paris, J., Phillippe, M. and Osborne, H.B. (1991) Degradation of a developmentally regulated mRNA in Xenopus embryos is controlled by the 3′ region and requires the translation of another maternal mRNA. Mol. Cell. Biol., 11, 3115-3124.
27. McMillan, J.P. and Singer, M.F. (1993) Translation of the human LINE-1 element, L1Hs. Proc. Natl Acad. Sci. USA, 90, 11533-11537.
28. Hess, M.A. and Duncan, R.F. (1996) Sequence and structure determinants of Drosophila Hsp70 mRNA translation: 5′UTR secondary structure specifically inhibits heat shock protein mRNA translation. Nucl. Acids Res., 24, 2441-2449.
29. Dorin, D., Bonnet, M.C., Bannwarth, S., Gatignol, A., Meurs, E.F. and Vaquero, C. (2003) The TAR RNA-binding protein, TRBP, stimulates the expression of TAR- containing RNAs in vitro and in vivo independently of its ability to inhibit the dsRNA-dependent kinase PKR. J. Biol. Chem., 278, 4440-4448.
30. Erard, M., Barker, D.G., Amalric, F., Jeang, K.T. and Gatignol, A. (1998) An Arg/Lys-rich core peptide mimics TRBP binding to the HIV-1 TAR RNA upper-stem/loop. J. Mol. Biol., 279, 1085-1099.
31. Tassone, F., Hagerman, R.J., Chamberlain, W.D. and Hagerman, P.J. (2000) Transcription of the FMR1 gene in individuals with fragile X syndrome. Am. J. Med. Genet., 97, 195-203.
32. Feng, Y., Zhang, F., Lokey, L.K., Chastain, J.L., Lakkis, L., Eberhart, D. and Warren, S.T. (1995) Translational suppression by trinucleotide repeat expansion at FMR1. Science, 268, 731-734.
33. Mankodi, A., Logigian, E., Callahan, L., McClain, C., White, R., Henderson, D., Krym, M. and Thornton, C.A. (2000) Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science, 289, 1769-1773.
34. (n) expansions associated with myotonic dystrophy. EMBO J, 19, 4439-4448.
35. Finsterer, J. (2002) Myotonic; dystrophy type 2. Eur. J. Neurol., 9, 441-447.
36. Mankodi, A. and Thornton, C.A. (2002) Myotonic syndromes. Curr. Opin. Neurol., 15, 545-552.
37. Salat, U., Bardoni, B., Wohrle, D. and Steinbach, P. (2000) Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations? J. Med. Genet., 37, 842-850.
38. Fu, Y.H., Kuhl, D.P., Pizzuti, A., Pieretti, M., Sutcliffe, J.S., Richards, S., Verkerk, A.J., Holden, J.J., Fenwick, R.G., Jr., Warren, S.T. et al. (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell, 67, 1047-1058.
39. Brown, W.T., Houck, G.E., Jr., Jeziorowska, A., Levinson, EN., Ding, X., Dobkin, C., Zhong, N., Henderson, J., Brooks, S.S. and Jenkins, E.C. (1993) Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAAM, 270, 1569-1575.
40. Zhong, N., Liu, X., Gou, S., Houck, G.E., Jr., Li, S., Dobkin, C. and Brown, W.T. (1994) Distribution of FMR-1 and associated microsatellite alleles in a normal Chinese population. Am. J. Med. Genet., 51, 417-422.
41. Garcia Arocena, a, Breece, K.E. and Hagerman, P.J. (2003) Distribution of CGG repeat sizes within the fragile X mental retardation 1 (FMR1) homologue in a non-human primate population. Hum. Genet., 7, 7.
42. Leehey, M.A., Munhoz, R.P., Lang, A.E., Brunberg, J.A., Grigsby, J., Greco, C., Jacquemont, S., Tassone, E, Lozano, A.M., Hagerman, P.J. et al. (2003) The fragile X premutation presenting as essential tremor. Arch. NeuroL, 60, 117-121.
43. Eichler, E.E., Kunst, C.B., Lugenbeel, K.A., Ryder, O.A., Davison, D., Warren, S.T. and Nelson, D.L. (1995) Evolution of the cryptic FMR1 CGG repeat. Nat. Genet., 11, 301-308.
44. Chong, S.S., Eichler, E.E., Nelson, D.L. and Hughes, M.R. (1994) Robust amplification and ethidium-visible detection of the fragile X syndrome CGG repeat using Pfu polymerase. Am. J. Med. Genet., 51, 522-526.